510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1445-2018Class II

SOMATOM Emotion 6 Intended to produce cross-sections images of the body by computer reconstruction of x-ray...

Siemens Medical Solutions USA, Inc. / initiated 2018-02-15 / Terminated / root cause: software

Siemens Medical Solutions USA, Inc began a recall of SOMATOM Emotion 6 Intended to produce cross-sections images of the body by computer reconstruction of x-ray transmission data on . FDA classified it as Class II and gives the reason as "To inform customers of possible incorrect tube current calculations by the CARE Dose4D algorithm for head scans based on p.a. (posterior-anterior) or a.p. (anterior-posterior) topograms. Depending on the geometrical...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1445-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Medical Solutions USA, Inc.
Product
SOMATOM Emotion 6 Intended to produce cross-sections images of the body by computer reconstruction of x-ray transmission data.
Product code
JAK System, X-Ray, Tomography, Computed
Reason for recall
To inform customers of possible incorrect tube current calculations by the CARE Dose4D algorithm for head scans based on p.a. (posterior-anterior) or a.p. (anterior-posterior) topograms. Depending on the geometrical shape of the skull bone, it may happen in rare cases that the calculated dose distribution is not appropriate and could lead to unnecessary radiation exposure
Root cause tag
software
FDA root cause
Software design
Action
The Center for Devices and Radiological Health (CDRH) understands that the CAP involving 1301 units will consist of the following: 1. You will contact customers and initiate the actions to correct the failure to comply issue. 2. You will provide a software update to correct tube current calculations by the CARE Dose4D algorithm for head scans. 3. You will follow-up with consignees to verify the effectiveness of the software update. CDRH approves the CAP subject to the following conditions: 1.Notification of all dealers and purchasers is to be made within 15 working days of receipt of this letter in the manner specified in 21 CFR 1003.21 and 1003.22. This office and the Food and Drug Administration (FDA) district office coordinator noted below are to be included in the notification. 2. Any future customer notification letters to be sent must comply with the requirements of 21 CFR 1003.21. This includes, but is not limited to, the prescribed packaging and the statement that you will remedy the defect or bring the product into compliance at no charge. You may proceed or continue with implementation of the CAP (subject to the conditions noted above). For further questions, please call (610) 219-4834.
Quantity in commerce
1301
Distribution
USA (nationally) Distribution.
Product codes and lots
10046766

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1445-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1445-2018Class IITerminatedVoluntary: Firm initiated
Z-1446-2018Class IITerminatedVoluntary: Firm initiated
Z-1447-2018Class IITerminatedVoluntary: Firm initiated
Z-1448-2018Class IITerminatedVoluntary: Firm initiated
Z-1449-2018Class IITerminatedVoluntary: Firm initiated
Z-1450-2018Class IITerminatedVoluntary: Firm initiated
Z-1451-2018Class IITerminatedVoluntary: Firm initiated
Z-1452-2018Class IITerminatedVoluntary: Firm initiated
Z-1453-2018Class IITerminatedVoluntary: Firm initiated
Z-1454-2018Class IITerminatedVoluntary: Firm initiated
Z-1455-2018Class IITerminatedVoluntary: Firm initiated
Z-1456-2018Class IITerminatedVoluntary: Firm initiated
Z-1457-2018Class IITerminatedVoluntary: Firm initiated
Z-1458-2018Class IITerminatedVoluntary: Firm initiated
Z-1459-2018Class IITerminatedVoluntary: Firm initiated